Navigation Links
Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
Date:4/9/2008

ent of specific ligands directed to target cell receptors. An additional key strength of the RNAi NPX delivery technology is its ability to incorporate multiple siRNAs in a single drug product. These multi-targeted therapeutics can simultaneously silence several mRNAs that represent parallel or synergistic elements of the same disease pathway resulting in a more comprehensive and/or novel therapeutic potential.

Recent technology licensing agreements with institutions such as the University of Massachusetts Medical School and the Massachusetts Institute of Technology have enhanced Intradigm's existing intellectual property portfolio and provided Intradigm with the rights and know-how to leverage a broad family of polymers and polymer structures, as well as next generation siRNA structures, in connection with its RNAi Nanoplex delivery technology.

ABOUT INTRADIGM

Intradigm is a private biotechnology company dedicated to the development of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases with an initial focus on oncology.

At present, Intradigm is working to build a high-value internal pipeline of RNAi oncology therapeutics, and is actively advancing its lead drug candidate, ICS-283, for a variety of cancer indications. The company is pursuing a comprehensive integrated RNAi therapeutic development strategy that incorporates advanced RNAi delivery technology, RNAi structural technology and novel, proprietary therapeutic siRNA sequences. For more information on Intradigm, please visit http://www.intradigm.com.

ABOUT THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL

The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attra
'/>"/>

SOURCE Intradigm Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
3. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
4. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
5. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
6. Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications
7. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
8. Syngenta Licenses Chromatin Gene Stacking Technology
9. Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation
10. Prometheus Licenses COLAL-PRED(R) From Alizyme
11. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... MA (PRWEB) September 17, 2014 Terracon ... version of its TerraPure tank . This addition ... is molded from FDA-compliant linear polyethylene and available in ... pre-installed fittings and ships in two weeks or less. ... features and benefits found in Terracon’s existing TerraPure tank ...
(Date:9/17/2014)... , Sept. 17, 2014 Alternative Fuels Americas, ... to form a Special Purpose Vehicle in partnership with Jatro ... centric agro energy company. The SPV shall be called AFAI ... with AFAI as majority shareholder. The SPV shall pursue Jatropha ... , particularly Ethiopia . ...
(Date:9/17/2014)... , Sept. 17, 2014 RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today announced that it has been granted a ... Office on its unique delivery system for delivering ... phagocytic cells for the treatment of diseases with ...
(Date:9/17/2014)... 2014 Escape Alert, LLC . filed international ... will alert owners if their pet has escaped and enable them ... microchip in the pet’s body. This is the first implantable ... have been around for many years, they are passive until read ... track a pet’s location or alert the owner that the pet ...
Breaking Biology Technology:Terracon Introduces Pre-Engineered TerraPure® Tank for Ultrapure Water Applications 2AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 2AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4Implantable Microchip for Pets with GPS Tracking - Patent Filed by Escape Alert, LLC. 2Implantable Microchip for Pets with GPS Tracking - Patent Filed by Escape Alert, LLC. 3
... strongest and most conductive material, discovered in 2004 at ... Professor Kostya Novoselov, has the potential to revolutionize material ... the two scientists the Nobel Prize for Physics last ... just announced plans for a 50m graphene research hub ...
... Oct. 7, 2011 For the third quarter of ... ranking in MD Buyline,s user satisfaction surveys by earning ... areas: stereotactic radiosurgery (SRS), linear accelerators (tie ... and treatment planning systems (TPS). For six consecutive quarters, ...
... 6, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: ... that the Company submitted its plan to cure stock ... the New York Stock Exchange ("NYSE") on October 5, ... American Oriental Bioengineering, Inc. is a ...
Cached Biology Technology:Graphene's 'Big Mac' creates next generation of chips 2Elekta Ranks as Top Vendor in MD Buyline Report for 3rd Quarter 2011 2
(Date:9/17/2014)... the Catalan Institute of Oncology-Bellvitge Biomedical Research Institute ... genes differentially expressed in normal accompanying cells in ... used to classify colorectal tumors, predict the evolution ... decisions to prevent relapses. , Biomarkers ... in our population considering both sexes. About 30,000 ...
(Date:9/17/2014)... a Carnegie expedition in Australia,s Great Barrier Reef has ... the mid-1970s. The scientists suggest that ocean acidification may ... , In a quest for historical context on ... measurements of the growth rate of a section of ... than 30 years ago. Their work is published in ...
(Date:9/17/2014)... new crime unit designed to fight food fraud ... meat being passed off as beef scientists from ... They describe their approach, which represents a vast improvement ... and Food Chemistry . , Hans-Ulrich Humpf and colleagues ... problem. But they also say that adding, for example, ...
Breaking Biology News(10 mins):Five genes to predict colorectal cancer relapses 2Coral growth rate plummets in 30-year comparison 2
... CA Newly launched nerve cells in a growing embryo must ... they use to navigate have yet to surface. In a study ... the Salk Institute for Biological Studies have recovered a key signal ... the spinal cord and must find their way down the length ...
... in the upcoming Acoustical Society of America (ASA) meeting ... World Wide pressroom even if they cannot attend in ... language papers selected from among the 600 talks and ... physics, sound engineering, marine biology, medicine, meteorology, and music. ...
... set up a new institute to focus funding, coordinate ... into cardiovascular disease, the cause of between 30 and ... The European Vascular Biology Institute (EVBI) is being presented ... 2007 with a specific brief to convert research into ...
Cached Biology News:Salk scientists identify key nerve navigation pathway 2Salk scientists identify key nerve navigation pathway 3Acoustics World Wide press room now open 2Acoustics World Wide press room now open 3Acoustics World Wide press room now open 4Proposal to step up cardiovascular disease research 2
37-1A9...
sPLA2-XII Human, Rabbit Polyconal Antibody Anti-Human sPLA2-XII Antibody was raised in rabbits against Human sPLA2-XII His-Tagged Fusion Protein Antigen: The recombinant human protein sPLA-XII...
...
Porcine Coronary Artery Smooth Muscle Cells (PCASMC) (>500,000 cells)...
Biology Products: